Cardiovascular Lesions of Kawasaki Disease: From Genetic Study to Clinical Management

Kuo, Ho-Chang; Chang, Wei‐Chiao

doi:10.5772/48341

Search citation statements

Order By: Relevance

Paper Sections

Select...

Abciximab1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 127 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The patients which were administered abciximab were superior because of higher rate of resolution of their aneurysms contrast to those who were provided with standard therapy alone [27]. Abciximab emerges to be advantageous in KD patients, particularly in those subjects who progress towards aneurysms [28].…”

Section: Abciximabmentioning

confidence: 99%

Kawasaki Disease – Options for Anti-Platelet Therapy

Alam¹

2017

Austin J Pharmacol Ther

View full text Add to dashboard Cite

Kawasaki disease is characterized by fever, redness, swelling and inflammation at various parts of body (lips, mouth and throat), conjunctivitis as well as swelling of lymphnodes around neck. The widely accepted therapy is high dose IVIG and acetylsalicylic acid. One of most common complication is coronary artery aneurysms which can lead to thrombosis. For the prevention of this cardiac complication which could be fatal, the patient is provided with platelet disaggregation therapy. There are several pharmacotherapeutic options: aspirin, clopidogrel, dipyridamole, prasugrel, abciximab, ticlopidine, cilostazol etc. Some of these drugs have been successfully used but for remaining the window for study is still open.

show abstract

Section: Abciximabmentioning

confidence: 99%

Kawasaki Disease – Options for Anti-Platelet Therapy

Alam¹

2017

Austin J Pharmacol Ther

View full text Add to dashboard Cite

show abstract

Cardiovascular Lesions of Kawasaki Disease: From Genetic Study to Clinical Management

Cited by 1 publication

References 127 publications

Kawasaki Disease – Options for Anti-Platelet Therapy

Kawasaki Disease – Options for Anti-Platelet Therapy

Contact Info

Product

Resources

About